RxDoctor Payments Data

Megan Shaw, MD

Rheumatology · Seattle, WANPI 1366608143

Payments from drug & device makers

No general payments reported

No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.

How this compares

$0 in reported general payments places this provider in the 15th percentile of 157 rheumatology providers in Washington.

See all rheumatology providers in Washington

Medicare billing

Part B allowed, 2024
$646,933
Medicare patients
397
Services billed
31,167

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab58$419,273
Skyrizi PenRisankizumab-Rzaa13$273,942
EnbrelEtanercept22$174,774
Xeljanz XrTofacitinib Citrate24$134,230
OtezlaApremilast14$67,411
TymlosAbaloparatide15$40,279
Colchicine77$5,017
Hydroxychloroquine Sulfate117$5,008
Cevimeline Hcl12$3,991
MethotrexateMethotrexate Sodium180$3,443
Mycophenolate Mofetil18$2,626
Prednisone191$1,567
Allopurinol109$1,274
Gabapentin106$1,204
Methylprednisolone48$1,089

Paid to pharmacies, not to this prescriber.

Other rheumatology in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →